Sara Grootwassink Lewis
CIK 1165970 · E.V.P. & CFO · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.07M
Companies
8
Total Filings
90
Lifetime Open-Market Net
-$1.52M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FCX | Director | 34,000 | $72.47 | $2.46M | $226.0K | 8 | 2026-06-02 |
| WY | Director | 26,023 | $23.38 | $608.4K | $297.2K | 15 | 2026-05-19 |
| HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Director | 65,488 | $17.10 | $1.12M | $588.8K | 12 | 2026-05-07 |
| PS BUSINESS PARKS, INC./MD (PSB) Delisted | Director | 8,868 | $187.44 | $1.66M | -$2.26M | 15 | 2018-06-18 |
| PCL | Director | 0 | $47.37 | $0 | $0 | 14 | 2016-02-19 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | — | $8.22 | — | $0 | 1 | 2015-05-18 |
| CAPITALSOURCE INC (CSE) Delisted | Director | 15,050 | — | — | $66.4K | 21 | 2013-04-29 |
| Elme Communities (WRE) Delisted | E.V.P. & CFO | 46,127 | $17.57 | $810.5K | -$436.4K | 4 | 2008-12-17 |
Recent Filings · Page 5 of 9
90 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-23 | WY | Grant (A) | +20,393 | $0 | EDGAR |
| 2016-02-19 | PCL | Disp (D) | −12,746 | $0 | EDGAR |
| 2016-02-16 | PCL | Grant (A) | +605 | $21.8K | EDGAR |
| 2016-02-04 | PCL | Grant (A) | +682 | $0 | EDGAR |
| 2016-01-08 | PCL | Grant (A) | +634 | $28.5K | EDGAR |
| 2015-10-01 | PCL | Grant (A) | +512 | $20.2K | EDGAR |
| 2015-07-02 | PCL | Grant (A) | +470 | $19.3K | EDGAR |
| 2015-05-18 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-30 | PS BUSINESS PARKS, INC./MD (PSB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-02 | PCL | Grant (A) | +464 | $20.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.